[HTML][HTML] Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism …
MN Elshafei, MFH Mohamed, A El-Bardissy… - Journal of Thrombosis …, 2021 - Springer
Direct oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
[PDF][PDF] Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism …
MN Elshafei, MFH Mohamed, A El‑Bardissy… - Journal of Thrombosis …, 2021 - academia.edu
Direct oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic …
MN Elshafei, MFH Mohamed… - … of thrombosis and …, 2021 - pubmed.ncbi.nlm.nih.gov
Direct oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
[HTML][HTML] Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism …
MN Elshafei, MFH Mohamed… - … of Thrombosis and …, 2021 - ncbi.nlm.nih.gov
Direct oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic …
MN Elshafei, MFH Mohamed, A El-Bardissy… - Journal of Thrombosis …, 2021 - elibrary.ru
Direct oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic …
MN Elshafei, MFH Mohamed, A El-Bardissy… - 2021 - qspace.qu.edu.qa
Direct oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic …
MN Elshafei, MFH Mohamed, A El-Bardissy… - … of Thrombosis and …, 2021 - europepmc.org
Direct oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic …
MN Elshafei, A El-Bardissy, AM Badie… - … of Thrombosis and …, 2021 - search.proquest.com
Direct oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
[PDF][PDF] Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism …
MN Elshafei, MFH Mohamed, A El‑Bardissy… - 2020 - researchgate.net
Direct oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic …
MN Elshafei, MFH Mohamed, A El-Bardissy… - Journal of Thrombosis …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Direct oral anticoagulant (DOAC) agents are
becoming the anticoagulation strategy of choice. However, their use in the treatment of acute …
becoming the anticoagulation strategy of choice. However, their use in the treatment of acute …